KeypointsTransoral Robotic Surgery (TORS) is becoming increasingly popular.Hemorrhage remains a complication with potential live threatening sequelae.In 122 patients receiving TORS there were 23 bleeding events following 19 operations (16%).Hemorrhage requiring a return to the operating room occurred after 7 operations (6%).There were no hemorrhage events in the 36 patients who received a synchronous neck dissection with transcervical ligation of the external carotid artery.INTRODUCTIONTransoral robotic surgery (TORS) received approval from the FDA in 2009 and has been utilised for a number of different indications in the upper aerodigestive tract (UADT), particularly for the surgical treatment of selected patients with cancer of the oropharynx. Traditional open surgical approaches with either mandibulotomy or lateral pharyngotomy provide a good oncological standard against which TORS can be compared. TORS has the advantage of overcoming line‐of‐sight restrictions, making it possible to access areas in the UADT that was not previously accessible and can avoid the morbidity of an open approach. TORS has been supported by a number of recent publications reporting the short‐ and medium‐term oncological outcomes from single institutional studies and a multi‐institutional study reporting a 3‐year survival rate of 92.5% and a 3‐year recurrence‐free rate of 88.8%. There has also been promising functional
Clinical Otolaryngology – Wiley
Published: Jan 1, 2018
Keywords: ; ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera